The Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV (the Panel) has reviewed and updated text and references of the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection.  

The following sections have been updated, and some section titles were revised to fit with updated content and the use of person-first language:  

• Clinical and Laboratory Monitoring of Pediatric HIV Infection 
• When to Initiate Antiretroviral Treatment in Children with HIV Infection 
• What to Start: Antiretroviral Treatment Regimens Recommended for Initial Therapy in Infants and Children with HIV 
• What Not to Start: Regimens Not Recommended for Initial Antiretroviral Therapy in Infants and Children
• Adherence to Antiretroviral Therapy in Children and Adolescents with HIV 
• Management of Children Receiving Antiretroviral Therapy 
• Appendix A: Pediatric Antiretroviral Drug Information 

Updates to the following sections are planned for August 2024: 

• Infant Feeding for Individuals with HIV in the United States 
• Diagnosis of HIV Infection in Infants and Children 
• Antiretroviral Management of Newborns with Perinatal HIV Exposure or HIV Infection 

For a list of recent updates, please see What's New in the Guidelines. To view or download the guidelines, please visit the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection of the Clinicalinfo website. The guidelines tables and recommendations also can be downloaded as separate PDF files. Recent updates are highlighted in yellow in the PDF versions. 

Clinicalinfo welcomes your feedback on the latest revisions to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Please send your comments with the subject line “Pediatric ARV Guidelines” to HIVinfo@NIH.gov by Thursday, July 18, 2024.